Literature DB >> 8932582

Immunogenetic profile of psoriasis vulgaris: association with haplotypes A2,B13,Cw6,DR7,DQA1*0201 and A1,B17,Cw6,DR7,DQA1*0201.

I Ikaheimo1, S Silvennoinen-Kassinen, J Karvonen, T Jarvinen, A Tiilikainen.   

Abstract

Psoriasis vulgaris is a skin disease with an immunological and genetic background present in 1-3% of the population. We studied the genetic susceptibility to psoriasis vulgaris in Finns with serological HLA typing and genomic HLA class II typing of the DQ and DP loci to evaluate the risk of developing psoriasis. The haplotypes most frequently distinguishing between psoriatics and controls were those that carried Cw6 (P < 10(-8)), DQA1*0201 (P = 9.3 x 10(-6)) and DR7 (P = 3.9 x 10(-5)). The two most frequent marker haplotypes were A2,B13,Cw6,DR7, DQA1*0201 and A1,B17,Cw6,DR7,DQA1*0201, which were not found among the control subjects. A deficit of haplotype B8,DR3,DQ2 (2 out of 124 in the patients versus 15 out of 106 in the controls, P = 1.5 x 10(-4)) was found, and this was in accordance with a slightly decreased frequency of DQA1*0501 (P = 3.1 x 10(-2)), which was usually linked with this haplotype. These results stimulate the research for a genetic resistance factor in psoriasis. Thus, this report sheds further light on the immunogenetic background of psoriasis in Finland. We conclude that the inheritance of psoriasis has a polygenic mode, in which the Cw6,DR7,DQA1*0201 combination seems to be important (P = 7.5 x 10(-7), relative risk 24.4, aetiological factor 0.29).

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8932582     DOI: 10.1007/bf02505045

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  25 in total

1.  Specific nucleotide sequence of HLA-C is strongly associated with psoriasis vulgaris.

Authors:  A Asahina; S Akazaki; H Nakagawa; S Kuwata; K Tokunaga; Y Ishibashi; T Juji
Journal:  J Invest Dermatol       Date:  1991-08       Impact factor: 8.551

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  HLA antigens in psoriasis. A family study.

Authors:  J Karvonen; A Tilikainen; A Lassus
Journal:  Ann Clin Res       Date:  1976-10

4.  The major histocompatibility complex in psoriasis vulgaris. III. HLA-C antigens.

Authors:  A Ozawa; I Matsuo; K Niizuma; M Ohkido; Y Nose; H Inouye; K Tsuji
Journal:  J Dermatol       Date:  1979-08       Impact factor: 4.005

5.  HLA B13, B17, B37 and Cw6 in psoriasis vulgaris: association with the age of onset.

Authors:  W Brenner; F Gschnait; W R Mayr
Journal:  Arch Dermatol Res       Date:  1978-08-28       Impact factor: 3.017

6.  HL-A antigens in psoriasis with special reference to the clinical type, age of onset, exacerbations after respiratory infections and occurrence of arthritis.

Authors:  J Karvonen
Journal:  Ann Clin Res       Date:  1975-10

7.  HLA-A,B,C and DR antigens in psoriasis.

Authors:  J A Marcusson; A Johannesson; E Möller
Journal:  Tissue Antigens       Date:  1981-05

Review 8.  The genetics of psoriasis.

Authors:  J T Elder; R P Nair; S W Guo; T Henseler; E Christophers; J J Voorhees
Journal:  Arch Dermatol       Date:  1994-02

9.  Specific restriction fragment length polymorphism on the HLA-C region and susceptibility to psoriasis vulgaris.

Authors:  A Ozawa; M Ohkido; H Inoko; A Ando; K Tsuji
Journal:  J Invest Dermatol       Date:  1988-03       Impact factor: 8.551

10.  Expression of HLA-DR molecules by keratinocytes, and presence of Langerhans cells in the dermal infiltrate of active psoriatic plaques.

Authors:  A B Gottlieb; B Lifshitz; S M Fu; L Staiano-Coico; C Y Wang; D M Carter
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  8 in total

1.  Reduced IFN-gamma responses associated with HLA-DR15 presentation of streptococcal cell wall proteins to dermal Th-1 cells in psoriasis.

Authors:  Barbara S Baker; Jean-Marc Ovigne; Vincent A Fischetti; Anne Powles; Lionel Fry
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

2.  Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C.

Authors:  R P Nair; P Stuart; T Henseler; S Jenisch; N V Chia; E Westphal; N J Schork; J Kim; H W Lim; E Christophers; J J Voorhees; J T Elder
Journal:  Am J Hum Genet       Date:  2000-05-05       Impact factor: 11.025

3.  T-cell involvement in drug-induced acute generalized exanthematous pustulosis.

Authors:  M Britschgi; U C Steiner; S Schmid; J P Depta; G Senti; A Bircher; C Burkhart; N Yawalkar; W J Pichler
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

4.  Inflammation-Induced Adhesin-Receptor Interaction Provides a Fitness Advantage to Uropathogenic E. coli during Chronic Infection.

Authors:  Matt S Conover; Ségolène Ruer; Joemar Taganna; Vasilios Kalas; Henri De Greve; Jerome S Pinkner; Karen W Dodson; Han Remaut; Scott J Hultgren
Journal:  Cell Host Microbe       Date:  2016-09-22       Impact factor: 21.023

5.  HLA risk haplotype Cw6,DR7,DQA1*0201 and HLA-Cw6 with reference to the clinical picture of psoriasis vulgaris.

Authors:  I Ikäheimo; A Tiilikainen; J Karvonen; S Silvennoinen-Kassinen
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

6.  Clinical Features and Genetic Polymorphism in Chinese Patients with Erythrodermic Psoriasis in a Single Dermatologic Clinic.

Authors:  Yang Lo; Hsien-Yi Chiu; Tsen-Fang Tsai
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

7.  Association of HLA Alleles and HLA Haplotypes with Psoriasis, Psoriatic Arthritis and Disease Severity in a Miscegenated Population.

Authors:  Flavia de Freire Cassia; Juliana Fernandes Cardoso; Luiz Cristovao Porto; Marcia Ramos-E-Silva; Sueli Carneiro
Journal:  Psoriasis (Auckl)       Date:  2021-05-10

8.  Hla-a and hla-B alleles associated in psoriasis patients from mumbai, Western India.

Authors:  Shankarkumar Umapathy; Aruna Pawar; R Mitra; D Khuperkar; J P Devaraj; K Ghosh; U Khopkar
Journal:  Indian J Dermatol       Date:  2011 Sep-Oct       Impact factor: 1.494

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.